These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16885873)

  • 1. [Should we screen for hepatocellular carcinoma?].
    Trinchet JC; Ganne-Carrié N
    Gastroenterol Clin Biol; 2006; 30(6-7):880-6. PubMed ID: 16885873
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
    Llovet JM
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of sonography in diagnosing hepatocellular carcinoma.
    Tarantino G
    AJR Am J Roentgenol; 2007 May; 188(5):W494; author reply W495. PubMed ID: 17449752
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance for hepatocellular carcinoma.
    Aqel BA; Ho SB
    Postgrad Med; 2006; 119(3):19-24. PubMed ID: 17128641
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
    Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
    Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma, appearance on computed tomography].
    Rangheard AS; Menu Y; Bléry M
    Presse Med; 2006 Apr; 35(4 Pt 2):728-9. PubMed ID: 16614622
    [No Abstract]   [Full Text] [Related]  

  • 7. Imaging of hepatocellular carcinoma: current concepts.
    Parikh A; Taouli B
    Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma. Frequency of diffuse inhomogenous forms in ultrasonography and comparative value of alphafetoprotein and ultrasonically guided fine needle aspiration biopsy.
    Sautereau D; Berry P; Cessot F; Gainant A; Pillegand B
    J Hepatol; 1992 Mar; 14(2-3):413-5. PubMed ID: 1380029
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemoperitoneum supporting difficult diagnosis of diffuse hepatocarcinoma in liver cirrhosis].
    Vignoli A; Cioni G; Sardini C; Tincani E; Cristani A; Ventura E
    Recenti Prog Med; 1994 Apr; 85(4):235-7. PubMed ID: 7517061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient spontaneous regression of hepatocellular carcinoma.
    Magalotti D; Gueli C; Zoli M
    Hepatogastroenterology; 1998; 45(24):2369-71. PubMed ID: 9951925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current methods for the diagnosis of hepatocellular carcinoma in cirrhosis. Towards a new strategy?].
    Beaugrand M
    Presse Med; 1990 May; 19(20):941-2. PubMed ID: 1693769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Imaging of nodules in cirrhosis: which nodules, which imaging, which management?].
    Bruel JM
    Gastroenterol Clin Biol; 1999 Jan; 23(1):97-100. PubMed ID: 10219609
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing for AFP in combination with ultrasound improves early liver cancer detection.
    Tzartzeva K; Singal AG
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):947-949. PubMed ID: 30118333
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinoma: available diagnostic tools and their limitations.
    Parvez T; Gumgumji AA; Raddadi MA; Rufai AA; Sabir AA; Ibraheim MI
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):57-60. PubMed ID: 14764268
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
    Senturk H; Cumali R
    Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
    Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
    Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
    Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.